Investor Relations

Latest Financial Results

Q3 2016

Quarter Ended Jun 30, 2016

Stock Information

Symbol

OTCQB: CTXR

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

Citius Pharmaceuticals (OTCQB: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius is currently advancing two proprietary product candidates, our Mino-Lok™ product and a hydrocortisone-lidocaine formulation. Citius believes the markets for its products are large and underserved by the current standard of care.

Contact Information

Investor Relations
Andrew Scott
VP of Investor Relations
T: 908-967-6677 ext. 105

Transfer Agent
VStock Transfer LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
www.vstocktransfer.com